Last reviewed · How we verify
NCT04980339
Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch Operation
trial in Arterial Switch Operation in 1,000 participants. Not yet recruiting.
31 October 2032
Quick facts
| Lead sponsor | Xie Mingxing |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 October 2022 |
| Primary completion | 31 October 2032 |
| Estimated completion | 31 October 2032 |
Conditions studied
- Arterial Switch Operation — all drugs for Arterial Switch Operation →
Sponsor
Xie Mingxing
Who can join
Eligibility, any sex, with Arterial Switch Operation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aims of this study are to 1. Identify the early and midterm outcomes in terms of mortality and reoperation of the arterial switch operation (ASO). 2. Identifying the influence of coronary artery anomalies on the in-hospital and post-discharge prognosis after ASO. 3. Evaluate the predictors for neoaortic valve regurgitation after ASO. 4. Explore the risk factors for neopulmonary artery stenosis after ASO.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04980339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Xie Mingxing trials
Trials by the same sponsor.
- NCT04964713 — A Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in Di · not yet recruiting
- NCT04976517 — Echocardiographic Assessment of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation · unknown
- NCT04974372 — A Multicenter Clinical Study of Ultrasound Multimodal Imaging in the Evaluation of Heart Transplantation · unknown
- NCT04966988 — Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart Transplantation · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04980339 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xie Mingxing
- Last refreshed: 13 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04980339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing